Filing Details
- Accession Number:
- 0001179110-18-011175
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-06 18:51:12
- Reporting Period:
- 2018-09-04
- Accepted Time:
- 2018-09-06 18:51:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1748208 | Joshua Foukas | 3838 West Parkway Blvd. Salt Lake City 84120 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-04 | 2,348 | $70.75 | 2,348 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-04 | 2,348 | $130.08 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 4,183 | $70.75 | 4,183 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-06 | 4,183 | $123.39 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock - Settles Stock Appreciation Right | Disposition | 2018-09-04 | 5,152 | $0.00 | 5,152 | $70.75 |
| Common Stock | Stock - Settles Stock Appreciation Right | Disposition | 2018-09-06 | 9,848 | $0.00 | 9,848 | $70.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,848 | 2018-09-01 | 2020-03-01 | No | 4 | M | Direct |
| 15,000 | 2018-09-01 | 2020-03-01 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
- Weighted average price $130.077. Price range in multiple transactions was $130.00 to $130.55 inclusively.
- Weighted average price $123.388. Price range in multiple transactions was $123.00 to $123.825 inclusively.
Billionaire Hedge Funds
